| 000 | 00934 a2200289 4500 | ||
|---|---|---|---|
| 005 | 20250513191917.0 | ||
| 264 | 0 | _c19991122 | |
| 008 | 199911s 0 0 eng d | ||
| 022 | _a1087-0156 | ||
| 024 | 7 |
_a10.1038/12826 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aHodgson, J | |
| 245 | 0 | 0 |
_aJohnson & Johnson acquires Centocor. _h[electronic resource] |
| 260 |
_bNature biotechnology _cSep 1999 |
||
| 300 |
_a844-5 p. _bdigital |
||
| 500 | _aPublication Type: News | ||
| 650 | 0 | 4 | _aAbciximab |
| 650 | 0 | 4 | _aAntibodies, Monoclonal |
| 650 | 0 | 4 | _aAnticoagulants |
| 650 | 0 | 4 |
_aBiotechnology _xeconomics |
| 650 | 0 | 4 |
_aCommerce _xeconomics |
| 650 | 0 | 4 |
_aDrug Industry _xeconomics |
| 650 | 0 | 4 | _aImmunoglobulin Fab Fragments |
| 650 | 0 | 4 | _aPlatelet Aggregation Inhibitors |
| 773 | 0 |
_tNature biotechnology _gvol. 17 _gno. 9 _gp. 844-5 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1038/12826 _zAvailable from publisher's website |
| 999 |
_c10429417 _d10429417 |
||